Cognition Therapeutics, Inc. (CGTX)
0.9796
-0.01
(-1.05%)
USD |
NASDAQ |
Sep 10, 16:00
0.95
-0.03
(-3.02%)
After-Hours: 20:00
Cognition Therapeutics Total Assets (Quarterly) : 38.90M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 38.90M |
| March 31, 2026 | 36.14M |
| December 31, 2025 | 48.39M |
| September 30, 2025 | 43.40M |
| June 30, 2025 | 19.62M |
| March 31, 2025 | 23.50M |
| December 31, 2024 | 30.23M |
| September 30, 2024 | 27.58M |
| June 30, 2024 | 34.37M |
| March 31, 2024 | 38.85M |
| December 31, 2023 | 35.16M |
| Date | Value |
|---|---|
| September 30, 2023 | 38.77M |
| June 30, 2023 | 43.96M |
| March 31, 2023 | 45.66M |
| December 31, 2022 | 50.42M |
| September 30, 2022 | 53.56M |
| June 30, 2022 | 52.81M |
| March 31, 2022 | 58.70M |
| December 31, 2021 | 59.14M |
| September 30, 2021 | 13.39M |
| June 30, 2021 | 17.29M |
| March 31, 2021 | 16.51M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Zevra Therapeutics, Inc. | 302.71M |
| Bristol Myers Squibb Co. | 87.63B |
| Structure Therapeutics, Inc. | 1.425B |
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.872M |
| Shareholders Equity (Quarterly) | 33.02M |
| Debt to Equity Ratio | 0.0178 |
| Current Ratio | 7.027 |
| Net Debt Paydown Yield | -0.02% |